Company / Income Tax per Share
MoonLake Immunotherapeutics Income Tax per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
+111.3%
vs FY2024
Sector context
#81 of 201
Health Care
What the data says
At $0.01, MoonLake Immunotherapeutics's income tax per share ranks #121 of 201 in the Health Care sector. Income Tax per Share has increased for 4 consecutive years, from $0.00 in FY2021 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of +97.1%.
Increased from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +97.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#121 of 201 in Health CareTop 60% of 201This company $0.01 Sector average $1.35
▼
-99.3% below sector average
Key checks
Key Insights
- MoonLake Immunotherapeutics's income tax per share has grown for 4 consecutive years.
- In FY2025, income tax per share increased 111.3% year-over-year.
- Ranks #81 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +111.3% |
| FY2024 | $0.00 | +134.4% |
| FY2023 | $0.00 | +54.5% |
| FY2022 | $0.00 | +104.2% |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026